These results not only confirm the pro-tumorigenic role of PD-L1 in ESCC, but also imply that its suppression via PSD3 may be part of a compensatory regulatory mechanism that favors immune evasion through PD-L1-independent routes. Here, PSD3 is linked to esophageal squamous cell carcinoma.